Itktm1.1Gsk
Targeted Allele Detail
|
Symbol: |
Itktm1.1Gsk |
Name: |
IL2 inducible T cell kinase; targeted mutation 1.1, GlaxoSmithKline |
MGI ID: |
MGI:5750989 |
Synonyms: |
ItkK390R |
Gene: |
Itk Location: Chr11:46215977-46280342 bp, - strand Genetic Position: Chr11, 27.75 cM
|
Alliance: |
Itktm1.1Gsk page
|
|
Germline Transmission: |
Earliest citation of germline transmission:
J:222505
|
Parent Cell Line: |
Not Specified (ES Cell)
|
Strain of Origin: |
BALB/c
|
|
Allele Type: |
|
Targeted (Not Applicable) |
Mutations: |
|
Insertion, Nucleotide substitutions
|
|
|
Mutation details: Exon 12 was replaced with a floxed, modified exon 12 in which nucleotide substitution results in the amino acid substitution of arginine for lysine at position 390 (K390R). Flp-mediated recombination removed the FRT-flanked neomycin resistance cassette inserted downstream of the modified exon 12.
(J:222505)
|
|
|
Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
Carrying any Itk Mutation: |
51 strains or lines available
|
|
Original: |
J:222505 Deakin A, et al., Characterisation of a K390R ITK kinase dead transgenic mouse--implications for ITK as a therapeutic target. PLoS One. 2014;9(9):e107490 |
All: |
1 reference(s) |
|